Leukoreduced PRP enhanced proliferation and ECM production yet inhibited senescence, inflammation, and multi-differentiation potential of AFSCs by downregulating HMGB1
CONCLUSION: Leukoreduced PRP promotes cell proliferation and ECM production of AFSCs, while inhibiting their senescence, inflammation, and multi-differentiation potentials via downregulating HMGB1 expression.PMID:37436160 | DOI:10.1080/08923973.2023.2232106
Source: Immunopharmacology and Immunotoxicology - Category: Allergy & Immunology Authors: Baoshan Hu Lianxin Wang Naikun Sun Gang Rui Shengrong Lin Source Type: research
More News: Allergy & Immunology | Genetics | New Zealand Health | Stem Cell Therapy | Stem Cells | Study